Dr Ashley Horne, Professor Corinne Faivre-Finn, Maria Moran and the lung team were nominated by Catherine for the care they gave her dad. 2/3

Brilliant to see some of our Manchester researchers at the European Lung Cancer Conference #ELCC24 in Prague sharing their expertise with lung cancer specialists from around the world 🌎 Congratulations to all those who have spoken and presented abstracts at this conference! 👏

Also fantastic to get an update on the CONCORDE trial testing novel DDRi drugs with radiotherapy in LA-NSCLC @LcsmUk at @BTOGORG - hoping to open at @BelfastTrust very soon! #radonc #BTOG22 @finn_corinne @AlastairGreyst2 @gerryhanna @DrSRBrown @K_Butterworth @AshHorne1983

Just logged in to the new @BTOGORG trainee network app (via @SlackHQ) - this will be great for sharing lung resources & project ideas/opportunities! #BTOG22

Watching another excellent @uoe_online oncology tutorial on uses of radiotherapy given to Year 2 @internalmeded Masters students by Dr Ashley Horne as part of the Oncology module run by Dr Colin Barrie @NHS_Lothian @NHSLothianMedEd @EdinCRC

ESPEN guidelines are comprehensive and recommend the screening for cachexia (including Glasgow Score) #NCRI2019 https://t.co/mLRKsotb5M

@PeterHall001 @JenRicher3 @AshHorne1983 I thought he was prepping for the exam! Good luck @AshHorne1983 and thanks for explaining the work so well at #ESMO19

Fabulous graphic from P378 @PeterHall001 and colleagues showing the multiple options available in the 'real world' for ER+ Her2- MBC #bcsm #ESMO19

#ESMO19 #LCSM Conclusions of @peters_solange about phase 3 CheckMate-227 evaluating Nivolumab + Ipilimumab for the first line setting of NSCLC.

BNOS 2017 - Sara Erridge 'Radiotherapy and SRS evidence' - @BNOSofficial @brainTumourOrg @smarino0111 @philohalloran @geoffcross #BNOS2017

The sun is out.. and it's mock exam day for the faculty and delegates on the 34th Cardiff FRCR revision course. It's been a long but fantastic week. Huge thanks to everyone who helped. Humbled by all the patients who came in today. Good luck for the exam! @VelindreCC @VCCMedEd

Exciting discussion re. an important controversy in #oncology: are genomic tests quantifying homologous recombination repair deficiency (HRD) useful for #cancer #treatment decision making? just published in ⁦@ESMO_Open⁩ by ⁦@myESMO⁩

How to optimize treatment decisions based on multi-omic biomarkers for immunotherapy in the future. Very interesting talk by Mitchell Levesque at Zurich ESMO immuno-oncology preceptorship @myESMO

Enjoying #atom2019 in Oxford. Good turn out from Edinburgh @frances_yuille #teamyuille @RCRadiologists